Champions Oncology (CSBR) Assets (2011 - 2026)

Champions Oncology has reported Assets for 16 years, with the latest figure at $27.0 million in Q2 2026.

• On a quarterly basis, Assets fell 16.56% year-over-year to $27.0 million in Q2 2026; TTM through Apr 2026 was $27.0 million, a 16.56% decrease from a year earlier, with the FY2026 full-year figure at $27.0 million, down 16.56% from the prior year.
• Assets was $27.0 million for Q2 2026 at Champions Oncology, down from $28.4 million in the prior quarter.
• The five-year high for Assets was $36.4 million in Q4 2022, with the low at $24.9 million in Q3 2024.
• Average Assets over 5 years is $30.6 million, with a median of $30.4 million recorded in 2025.
• The sharpest annual moves came in 2022 and 2024: Assets soared 32.95% in 2022, then dropped 25.9% in 2024.
• Over 5 years, Assets stood at $36.4 million in 2022, then declined by 22.19% to $28.3 million in 2023, then slipped by 10.79% to $25.2 million in 2024, then rose by 19.5% to $30.2 million in 2025, then decreased by 10.52% to $27.0 million in 2026.
• The last three Assets figures came in at $27.0 million (Q2 2026), $28.4 million (Q1 2026), and $30.2 million (Q4 2025), per Business Quant data.